(Q39036434)

English

Pomegranate extract (POMx) decreases the atherogenicity of serum and of human monocyte-derived macrophages (HMDM) in simvastatin-treated hypercholesterolemic patients: a double-blinded, placebo-controlled, randomized, prospective pilot study

scientific article published on 19 November 2013

Statements

Pomegranate extract (POMx) decreases the atherogenicity of serum and of human monocyte-derived macrophages (HMDM) in simvastatin-treated hypercholesterolemic patients: a double-blinded, placebo-controlled, randomized, prospective pilot study (English)
Shadi Hamoud
Tony Hayek
Nina Volkova
Judith Attias
Danit Moscoviz
Mira Rosenblat
Michael Aviram
19 November 2013
204-210

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit